Merck Serono Limited: UK Public Sector Contracts Won & Awards

Large organisationCompanies House: Private Limited CompanyFelthamNationwide (UK)Main market: Pharmaceutical products

Official UK PPONPYQR-6988-GHRWCompanies House00990823 ↗ · Active

Where they win
i

38 awards (36 for a named lot, 95%, 2 for a whole procedure with no lot named) · top CPV classes, shares of all 38 awards. An award may cover more than one class.

3360 Pharmaceutical products38 awards · 100% · 36 awards naming a lot + 2 whole-procedure awards
Attributable award value
i
£36mOn 2 of 38 award records; the five largest make 100%. Largest rows below.

Where their buyers are
i

ITL1 region of the buyer office · known for 37 of 37 awarded procedures · each procedure counts once

Greater London24 procedures · 65%
Scotland8 procedures · 22%
North West England4 procedures · 11%
Northern Ireland1 procedure · 3%

Bidding record
i

Procurement Act 2023 award notices name every bidder · 1 notice names this supplier since 21 Jul 2026 · observed bids, not an estimate

Contract lots contested
i
0 won · 0 lostFewer than three decided lots: no rate is claimed.
Framework / DPS places
i
1 of 1
Authorities bid for
i
1

Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.

Who they sell to
i

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i
  • NHS & health95%(36 awards)
    36 of 38 awards are NHS & health (95%).
  • Type not classified5%(2 awards)
    2 of 38 awards are Type not classified (5%).
AuthorityProceduresShareAward recordsLast activity
NHS Englandframework/DPS on 222464.9%286 Jul 2026
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")framework/DPS on 6821.6%149 Apr 2025
The NHS Commissioning Board (operating under the name of NHS England)framework/DPS on 4410.8%47 Feb 2022
Regional Business Services Organisation Procurement and Logistics Serviceframework/DPS on 112.7%212 Jun 2025

Share = of the 37 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

40 of 48 awards carry an end date, 12 estimated from the duration · not a retender forecast

ContractEndsPublished value
Lot 1 - Follitropin Alfa30 Nov 2026 estimated£2,190,252 ceiling
Lot 4 - Progesterones30 Nov 2026 estimated£1,438,484 ceiling
Lot 5 - Gonadotrophin Releasing Hormone - GNRH Antagonists30 Nov 2026 estimated£613,944 ceiling
Lot 6 - All Other Fertility Products30 Nov 2026 estimated£158,400 ceiling
Lot 2 - Gonadotrophins30 Nov 2026 estimated£359,160 ceiling
Medicinal Products - Direct to Trust2 Jun 2027 estimated£210,000,000 ceiling
Medicinal Products - with Pharma Funded Homecare Services2 Jun 2027 estimated£174,000,000 ceiling
Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab28 Jun 2027 estimated£47,968,904 ceiling
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National31 Aug 2027£261,895,933
Growth Hormone Daily Dose23 Dec 2027 estimated£15,300,000 ceiling

Soonest 10 of 11.

Recent awards

Latest 30 of 38 award records naming this supplier

Contracts Finder adds 10 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.

Award / procedureAuthorityAwardedPublished value
Lot 1 - CM/PHR/25/5730/01 - NHS Branded Medicines Tranche A for Midlands & EastNHS England15 Jun 2026£665,389,588
framework ceiling · 1 of 25 appointed suppliers
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026NHS EnglandNot published£665,389,588 †
framework ceiling · 1 of 24 appointed suppliers
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
Medicinal Products - Direct to TrustRegional Business Services Organisation Procurement and Logistics ServiceNot published£210,000,000 †
framework ceiling · 1 of 31 appointed suppliers
Medicinal Products - with Pharma Funded Homecare ServicesRegional Business Services Organisation Procurement and Logistics ServiceNot published£174,000,000 †
framework ceiling · 1 of 21 appointed suppliers
Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumabThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£47,968,904 †
framework ceiling · 1 of 6 appointed suppliers
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
Growth Hormone Daily DoseThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£15,300,000 †
framework ceiling · 1 of 4 appointed suppliers
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche ANHS EnglandNot published£1 †
framework ceiling · not attributable revenue
About this data
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
  • Contract end dates. Published on 28 of 48 awards, estimated from the published duration on 12 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
  • Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.